EXAS vs PACK · rev $2.76B vs rev $368.9M
EXACT Sciences Corporation (EXAS) versus Ranpak Holdings Corp (PACK) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Ranpak Holdings Corp (PACK) is a packaging & containers company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported PACK revenue for 2024-12-31 was $368.9M. Net income was -$21.5M. Revenue was up 9.7% from 2023-12-31 to 2024-12-31. PACK currently screens at market cap $617.6M.
EXAS currently screens at market cap $20.03B. PACK currently screens at market cap $617.6M.
Not investment advice. Open the EXAS and PACK stock pages for the full models.
Not investment advice.